Activation of the alternative complement pathway.
D000818:Animals; D001323:Autoantibodies; D003167:Complement Activation; D003176:Complement C3; D003178:Complement C3 Nephritic Factor / Q000378:metabolism; D050577:Complement C3-C5 Convertases / Q000096:biosynthesis / Q000378:metabolism; D003179:Complement C3b / Q000096:biosynthesis / Q000378:metabolism; D003180:Complement C3b Inactivator Proteins / Q000378:metabolism; D003182:Complement C5 / Q000378:metabolism; D011415:Complement Factor B; D011416:Complement Factor D; D017242:Complement Factor H; D003170:Complement Pathway, Alternative; D006168:Guinea Pigs; D006801:Humans; D007113:Immunity, Innate; D007074:Immunoglobulin G / Q000378:metabolism; D009000:Monocytes / Q000276:immunology; D011414:Properdin / Q000378:metabolism; D011817:Rabbits; D012794:Sialic Acids / Q000172:deficiency / Q000494:pharmacology
D001323:Autoantibodies; C493495:CFH protein, human; D003176:Complement C3; D003178:Complement C3 Nephritic Factor; D003180:Complement C3b Inactivator Proteins; D003182:Complement C5; D007074:Immunoglobulin G; D012794:Sialic Acids; D011414:Properdin; D003179:Complement C3b; D017242:Complement Factor H; D050577:Complement C3-C5 Convertases; C493488:CFD protein, human; D011416:Complement Factor D; D011415:Complement Factor B